156 related articles for article (PubMed ID: 22504916)
1. New perspectives in the therapy of chronic hepatitis B.
Lampertico P; Liaw YF
Gut; 2012 May; 61 Suppl 1():i18-24. PubMed ID: 22504916
[No Abstract] [Full Text] [Related]
2. [Protocol for the antiviral therapy of chronic hepatitis B].
;
Orv Hetil; 2008 Dec; 149(49):2341-3. PubMed ID: 19042187
[No Abstract] [Full Text] [Related]
3. [Recent therapies for hepatitis B (discussion)].
Tanaka E; Suzuki F; Tanaka Y; Shiryu H
Nihon Shokakibyo Gakkai Zasshi; 2007 Oct; 104(10):1465-79. PubMed ID: 17917394
[No Abstract] [Full Text] [Related]
4. Letter: Treatment of HBeAg+ chronic hepatitis B--is tenofovir truly superior to entecavir?
Sadler MD; Lee SS
Aliment Pharmacol Ther; 2014 Jun; 39(11):1339. PubMed ID: 24803253
[No Abstract] [Full Text] [Related]
5. Commentary: tenofovir is superior to entecavir in HBeAg-positive chronic hepatitis B patients.
Bradshaw D; Danta M
Aliment Pharmacol Ther; 2014 May; 39(9):992. PubMed ID: 24689343
[No Abstract] [Full Text] [Related]
6. Quantification of serum hepatitis B surface antigen: is it useful for the management of chronic hepatitis B?
Janssen HL; Sonneveld MJ; Brunetto MR
Gut; 2012 May; 61(5):641-5. PubMed ID: 22180061
[No Abstract] [Full Text] [Related]
7. Letter: Treatment of HBeAg+ chronic hepatitis B--is tenofovir truly superior to entecavir? Authors' reply.
Gao L; Trinh HN; Li J; Nguyen MH
Aliment Pharmacol Ther; 2014 Jun; 39(11):1339-40. PubMed ID: 24803254
[No Abstract] [Full Text] [Related]
8. Commentary: tenofovir is superior to entecavir in HBeAg-positive chronic hepatitis B patients--authors' reply.
Gao L; Trinh HN; Li J; Nguyen MH
Aliment Pharmacol Ther; 2014 May; 39(9):993. PubMed ID: 24689344
[No Abstract] [Full Text] [Related]
9. [Protocol for the antiviral therapy of hepatitis B and D].
; ; Gervain J; Horváth G; Hunyady B; Makara M; Pár A; Szalay F; Tornai I; Telegdy L
Orv Hetil; 2010 Jan; 151(1):24-8. PubMed ID: 20031523
[No Abstract] [Full Text] [Related]
10. [Comparison of efficacy between adefovir dipivoxil and entecavir in patients with chronic hepatitis B].
Yang F; Wu XF; Wei N
Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):65-6. PubMed ID: 20128975
[No Abstract] [Full Text] [Related]
11. [Efficacy and treatment strategy for drug resistances of nucleos(t)ide analogues for chronic hepatitis B].
Hosaka T; Suzuki F; Kumada H
Nihon Shokakibyo Gakkai Zasshi; 2011 Feb; 108(2):210-4. PubMed ID: 21307624
[No Abstract] [Full Text] [Related]
12. [The efficacy of nucleoside/nucleotide analogue on chronic hepatitis B].
Lin Q; Zhang DZ
Zhonghua Gan Zang Bing Za Zhi; 2009 Oct; 17(10):722-5. PubMed ID: 19874684
[No Abstract] [Full Text] [Related]
13. Letter: First-line monotherapies for chronic hepatitis B - indirect comparison between entecavir and tenofovir.
Maratea D; Fadda V; Trippoli S; Messori A
Aliment Pharmacol Ther; 2013 Mar; 37(5):584-5. PubMed ID: 23369168
[No Abstract] [Full Text] [Related]
14. [The past, present and future treatment for chronic hepatitis B].
Okanoue T; Minami M
Nihon Rinsho; 2011 May; 69 Suppl 4():469-74. PubMed ID: 22096963
[No Abstract] [Full Text] [Related]
15. Tenofovir rescue regimen following prior suboptimal response to entecavir and adefovir combination therapy in chronic hepatitis B patients exposed to multiple treatment failures.
Zhang Q; Han T; Nie CY; Ha FS; Liu L; Liu H
J Med Virol; 2015 Jun; 87(6):1013-21. PubMed ID: 25716029
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus with primary resistance to adefovir.
Chang TT; Lai CL
N Engl J Med; 2006 Jul; 355(3):322-3; author reply 323. PubMed ID: 16855278
[No Abstract] [Full Text] [Related]
17. Pharmacotherapy of hepatitis B infection: a brief review.
Quan DJ
Nephrol Nurs J; 2008; 35(5):507-10, 534. PubMed ID: 18856082
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B: explosion of new knowledge.
Keeffe EB
Gastroenterology; 2007 Nov; 133(5):1718-21. PubMed ID: 17983813
[No Abstract] [Full Text] [Related]
19. Comparison of the efficacy of tenofovir and entecavir for the treatment of nucleos(t)ide-naive patients with chronic hepatitis B.
Doğan ÜB; Kara B; Gümürdülü Y; Soylu A; Akin MS
Turk J Gastroenterol; 2012 Jun; 23(3):247-52. PubMed ID: 22798114
[TBL] [Abstract][Full Text] [Related]
20. Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses.
Woo G; Tomlinson G; Nishikawa Y; Kowgier M; Sherman M; Wong DK; Pham B; Ungar WJ; Einarson TR; Heathcote EJ; Krahn M
Gastroenterology; 2010 Oct; 139(4):1218-29. PubMed ID: 20600036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
